BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27118999)

  • 1. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
    Draht MX; Smits KM; Jooste V; Tournier B; Vervoort M; Ramaekers C; Chapusot C; Weijenberg MP; van Engeland M; Melotte V
    Clin Epigenetics; 2016; 8():44. PubMed ID: 27118999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
    Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
    Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response.
    Switzeny OJ; Christmann M; Renovanz M; Giese A; Sommer C; Kaina B
    Clin Epigenetics; 2016; 8():49. PubMed ID: 27158275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms.
    Xiao Z; Li B; Wang G; Zhu W; Wang Z; Lin J; Xu A; Wang X
    Clin Chim Acta; 2014 Apr; 431():154-63. PubMed ID: 24518356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region of interest methylation analysis: a comparison of MSP with MS-HRM and direct BSP.
    Akika R; Awada Z; Mogharbil N; Zgheib NK
    Mol Biol Rep; 2017 Jul; 44(3):295-305. PubMed ID: 28676996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM.
    Kristensen LS; Wojdacz TK; Thestrup BB; Wiuf C; Hager H; Hansen LL
    BMC Cancer; 2009 Dec; 9():453. PubMed ID: 20025721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of methods to determine DNA methylation levels of a tumor-related microRNA gene.
    Konishi Y; Hayashi H; Suzuki H; Yamamoto E; Sugisaki H; Higashimoto H
    Anal Biochem; 2015 Sep; 484():66-71. PubMed ID: 25979762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.
    Liu W; Guan M; Su B; Li J; Ma W; Liu C; Li M; Lin Y; Lu Y
    Clin Chim Acta; 2010 Jul; 411(13-14):940-6. PubMed ID: 20227403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.
    Quillien V; Lavenu A; Karayan-Tapon L; Carpentier C; Labussière M; Lesimple T; Chinot O; Wager M; Honnorat J; Saikali S; Fina F; Sanson M; Figarella-Branger D
    Cancer; 2012 Sep; 118(17):4201-11. PubMed ID: 22294349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies.
    Wojdacz TK; Møller TH; Thestrup BB; Kristensen LS; Hansen LL
    Expert Rev Mol Diagn; 2010 Jul; 10(5):575-80. PubMed ID: 20629507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of methylation-sensitive high resolution melting for the detection of DNA methylation in cholangiocarcinoma.
    Amornpisutt R; Sriraksa R; Limpaiboon T
    Clin Biochem; 2012 Sep; 45(13-14):1092-4. PubMed ID: 22569599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSP-HTPrimer: a high-throughput primer design tool to improve assay design for DNA methylation analysis in epigenetics.
    Pandey RV; Pulverer W; Kallmeyer R; Beikircher G; Pabinger S; Kriegner A; Weinhäusel A
    Clin Epigenetics; 2016; 8():101. PubMed ID: 27688817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-Sensitive High Resolution Melting (MS-HRM).
    Hussmann D; Hansen LL
    Methods Mol Biol; 2018; 1708():551-571. PubMed ID: 29224163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
    Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation.
    Migheli F; Stoccoro A; Coppedè F; Wan Omar WA; Failli A; Consolini R; Seccia M; Spisni R; Miccoli P; Mathers JC; Migliore L
    PLoS One; 2013; 8(1):e52501. PubMed ID: 23326336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation.
    Wojdacz TK; Dobrovic A
    Nucleic Acids Res; 2007; 35(6):e41. PubMed ID: 17289753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
    J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
    Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation.
    Candiloro IL; Mikeska T; Dobrovic A
    Epigenetics; 2011 Apr; 6(4):500-7. PubMed ID: 21364322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.